PHMR Consulting

The alerts service provided by phmr consulting is rapidly becoming the industry standard for staying on top of the monthly literature in health economic, health outcomes, pricing and effectiveness.

The monthly alerts are so far available in the following disease areas.

Click to download PDFs of the front page of our January and February editions of the reports. If you are interested in seeing a full report please contact markratcliffe@phmrconsulting.com stating which disease area you are interested in.

> Schizophrenia
> Depression
> Bipolar Disorder
> ADHD
> Breast Cancer
> Lung Cancer
> Osteoporosis
> Diabetes
> CHD/CVD
> Migraine
> Parkinsons disease
> Alzheimer's disease

We are expanding the list of disease areas covered by the reports in line with customer requirements all the time.

The reports utilise a variety of search strings and literature databases but essentially exceeds best documented practice on literature searching. Once the hand searches are completed for that month’s new publications, we prioritise the papers for the company and review the most important ones. Finally, we provide an editorial on the new trends in the literature that month. Each report also contains as an appendix the new studies entering clinical trials.gov that month so the reader can be aware of what new data will potentially be coming to the market.

The feedback we have received so far makes it clear that the reports have high utility through the drug development process, when keeping on top of the literature is critical to investment decision making, clinical trial design etc, etc, etc. Further, that the reports have extremely high utility once the product is on the market, when keeping on top of the competition and potential new market sensitive data is critical to continued success. We now have several companies who are utilising the alerts as monthly updates to the core value dossiers for products.

The report is published on the same day of each month and sent to all the people in the company who would like to receive it. So for example it could come to the companies Director of HE/HO or therapy area lead scientist and they then forward it on to their own internal distribution list. Or the company provides us with the email addresses and we send it out to the entire distribution list.